- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06885866
Emotion Focused Internet Delivered Treatment for Adults with Eating Disorders
The goal of this clinical trial is to develop and test a new internet delivered treatment for adult patients with eating disorders, focused on developing normalized eating patterns and emotion regulation skills. The main focus is to investigate the additional effect of emotion regulation interventions, beyond the effect of other central tratment components normally included in evidence based eating disorder treatment.
The internet delivered treatment is divided into two phases, phase A and phase B. Phase A focus on establishing normalised eating patterns, and in phase B the emotion regulation interventions are added. Participants will get access to treatment modules every third day over a time period of 8.5 weeks, each module consist of psychopedagogical material, excercises and home work.
Data will be collected via the online research platform every third day during the treatment. Data is also collected at more comprehensive assessment points pre-treatment, post-treatment, and follow up 3 months after end of treatment.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study uses an experimental single-case design, specifically a randomized replicated AB design.
The baseline lenght (i.e., phase A) is randomized for each participant. There is six possible assignments, as the randomization is restricted to give all participants minimum 8 and maximum 12 treatment modules in each phase, with minimum 9 and maximum 14 baseline assessment points.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Östergötland
-
Linköping, Östergötland, Sweden, 58183
- Linköping University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- DSM5 eating disorder
- Minimum 18 years old
- Ongoing contact with a psychiatric clinic in sweden
Exclusion Criteria:
- Body mass index below 18,5
- Somatic instability due to eating disorder severeness
- High risk of suicide or severe self-harm
- Ongoing addiction or substance abuse
- Ongoing psychological treatment or psychotherapy
- New or changed mediciation for psychiatric disorders in the past 2 months
- Planned or ongoing pregnancy or recently gave birth
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Emotion regulation treatment
|
Emotion regulation intervention in two phases.
Phase A focus on establishing normalised eating patterns, and in phase B the emotion regulation interventions are added.
Participants will get access to treatment modules every third day over a time period of 8.5 weeks, each module consist of psychopedagogical material, excercises and home work.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difficulties in Emotion Regulation Scale, 36 items
Time Frame: At pre-treatment assessment one week before treatment start; at post-treatment assessment at day 63 counted from treatment start; and at follow-up assessment at day 153 counted from treatment start.
|
Assessment of emotion regulation difficulties.
36 items scored 1-5, higher scores indicate more difficulties.
Total score range from 36-180.
|
At pre-treatment assessment one week before treatment start; at post-treatment assessment at day 63 counted from treatment start; and at follow-up assessment at day 153 counted from treatment start.
|
|
Difficulties in Emotion Regulation Scale, 16 items
Time Frame: Counted from treatment start: at day 1, 4, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, 48, 51, 54, 57, 60
|
Assessment of emotion regulation difficulties, short version.
16 items scored 1-5.
Higher scores indicates more difficulties.
Total score range from 16-80.
|
Counted from treatment start: at day 1, 4, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, 48, 51, 54, 57, 60
|
|
The Positive and Negative Affect Schedule, short form
Time Frame: Counted from treatment start: at day 1, 4, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, 48, 51, 54, 57, 60
|
Assessment of affect levels.
In this study, only the subscale measuring negative affect is used.
5 items scored 1-5.
Higher scores indicate higher levels of negative affect.
Total score range from 5-25.
|
Counted from treatment start: at day 1, 4, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, 48, 51, 54, 57, 60
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Eating Disorder Examination Questionnaire 6.0
Time Frame: At pre-treatment assessment one week before treatment start; at post-treatment assessment at day 63 counted from treatment start; and at follow-up assessment at day 153 counted from treatment start.
|
Assessment of eating disorder symptoms.
28 items scored 0-6.
Higher scores represent more eating disorder pathology.
Scores are summerized and scaled, giving a total score ranging from 0-6.
|
At pre-treatment assessment one week before treatment start; at post-treatment assessment at day 63 counted from treatment start; and at follow-up assessment at day 153 counted from treatment start.
|
|
Eating Disorder Symptom List
Time Frame: Counted from treatment start: at day 1, 4, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, 48, 51, 54, 57, 60
|
Assessment of eating disorder symptoms.
8 items scored 0-3, with higher scores indicating more frequent eating disorder symptoms.
Total score range from 0-24.
|
Counted from treatment start: at day 1, 4, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, 48, 51, 54, 57, 60
|
|
Clinical Impairment Assessment
Time Frame: At pre-treatment assessment one week before treatment start; at post-treatment assessment at day 63 counted from treatment start; and at follow-up assessment at day 153 counted from treatment start.
|
Assessment of eating disorder related psychosocial impairment.
16 items scored 0-3.
Higher scores indicate higher impairment.
Total score range from 0-48.
|
At pre-treatment assessment one week before treatment start; at post-treatment assessment at day 63 counted from treatment start; and at follow-up assessment at day 153 counted from treatment start.
|
|
Clinical Impairment Assessment, subscale social
Time Frame: Counted from treatment start: at day 1, 4, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, 48, 51, 54, 57, 60
|
Assessment of eating disorder related psychosocial impairment, subscale focusing on social impariment. 5 items scored 0-3. Higher scores indicate higher impairment. Total score range from 0-15. |
Counted from treatment start: at day 1, 4, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, 48, 51, 54, 57, 60
|
|
Normalized eating pattern
Time Frame: Counted from treatment start: at day 1, 4, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, 48, 51, 54, 57, 60
|
Self-assessment of eating patterns, developed by the authors for use in the present study. The self-assessment includes 2 questions:
Items are scored 0-3. Higher scores indicare more normalized meal habits. Lower scores indicate disordered eating. Total score range from 0-6. |
Counted from treatment start: at day 1, 4, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, 48, 51, 54, 57, 60
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hugo Hesser, PhD, Örebro University, Linköping University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IBL-2021-00215
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Eating Disorders
-
Ibn Haldun UniversityCompletedDisordered Eating Behaviors | Eating Pathology | Eating Disorders SymptomsTurkey
-
Ibn Haldun UniversityActive, not recruitingDisordered Eating Behaviors | Eating Pathology | Eating Disorder SymptomsTurkey
-
University of PalermoUniversity of Padova; University of CatanzaroRecruitingEating Disorders | Eating Behavior | Eating Disorder SymptomItaly
-
Axsome Therapeutics, Inc.Enrolling by invitationBinge-Eating DisorderUnited States
-
BioprojetCompleted
-
Axsome Therapeutics, Inc.RecruitingBinge-Eating DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedBinge-Eating DisorderUnited States
-
Bezmialem Vakif UniversityMuğla Sıtkı Koçman University; The Scientific and Technological Research Council... and other collaboratorsActive, not recruitingEating Disorders | Eating Behavior | Orthodontic Appliance Complication | Eating HabitTurkey
-
Ali RezaiActive, not recruiting
-
University of Sao Paulo General HospitalActive, not recruitingBinge Eating DisorderBrazil
Clinical Trials on Emotion regulation treatment
-
Karolinska InstitutetCompleted
-
University Hospital TuebingenUnknownDepressive Disorder | Depression | RuminationGermany
-
McMaster UniversityNot yet recruiting
-
University Medical Center GroningenRecruitingStroke | Multiple Sclerosis | Brain TumorNetherlands
-
Teachers College, Columbia UniversityRecruitingDepression | Anxiety | Distress, Emotional | Rumination | Self-Criticism | WorryUnited States
-
Icahn School of Medicine at Mount SinaiNational Institute on Disability, Independent Living, and Rehabilitation...CompletedTraumatic Brain Injury | Executive Dysfunction | Emotion Dysregulation | Emotion DysfunctionUnited States
-
Teachers College, Columbia UniversityUniversity of MichiganCompletedDepression | Anxiety | Distress, Emotional | Emotional DysfunctionUnited States
-
Universitat Jaume IConsorcio Hospitalario Provincial de CastellónCompletedDepression | AnxietySpain
-
Douglas MenninWeill Medical College of Cornell University; Kent State UniversityCompletedGeneralized Anxiety Disorder | Depression, Anxiety | Anxiety Disorders and Symptoms | Emotional DysfunctionUnited States
-
Region ÖstergötlandCompletedBehavioral Symptoms | Emotional InstabilitySweden